menu search

HOOKIPA Pharma Reports First Quarter 2023 Financial Results and Recent Business Highlights

HOOKIPA Pharma Reports First Quarter 2023 Financial Results and Recent Business Highlights
HOOKIPA on track to report Phase 2 data on HB-200 for head and neck cancer in combination with pembrolizumab in 2Q 2023 Phase 1 clinical trials initiated for two programs (HB-300 for advanced prostate cancer and Gilead-partnered HB-400 for chronic hepatitis B) HB-700 for KRAS-mutated cancers achieved $10 million milestone payment in Roche collaboration NEW […] The post HOOKIPA Pharma Reports First Quarter 2023 Financial Results and Recent Business Highlights appeared first on ForexTV... Read More
Posted: May 11 2023, 11:01
Author Name: forextv
Views: 101923

Search within

Pages Search Results: